Repurposing the serotonin agonist Tegaserod as an anticancer agent in melanoma: molecular mechanisms and clinical implicationsWei Liu, Aleksandra A. Pandyra, Dieter Häussinger et al.|Journal of Experimental & Clinical Cancer Research|2020Cited by 51